This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / UniQure Securities Fraud Class Action Lawsuit
Regulatory class action lawsuit

UniQure Securities Fraud Class Action Lawsuit

Analysis based on 12 articles · First reported Feb 12, 2026 · Last updated Mar 05, 2026

Sentiment
-20
Attention
2
Articles
12
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market is negatively impacted by the news of a securities fraud class action lawsuit against UniQure, potentially leading to a decrease in UniQure's stock price. This event highlights the risks associated with investing in companies facing legal challenges over product claims.

Biotechnology Legal Services
Event Summary

Bernstein Liebhard LLP has announced a securities fraud class action lawsuit against UniQure N.V. on behalf of investors who purchased shares between September 24, 2025, and October 31, 2025. The lawsuit, filed in the United States===United States District Court for the Southern District of New York, alleges that UniQure and its senior officers made misrepresentations concerning AMT-130, a drug being developed for Huntington's Disease. Investors have until April 13, 2026, to file papers to serve as lead plaintiff. This legal action could result in significant financial and reputational consequences for UniQure.

Key Actions
100 Bernstein Liebhard LLP filed a securities fraud class action lawsuit UniQure
90 UniQure made alleged misrepresentations concerning AMT-130
Entities Involved
stock
UniQure
UniQure is facing a securities fraud class action lawsuit due to alleged misrepresentations regarding its drug AMT-130. This lawsuit could lead to significant financial penalties and reputational damage for UniQure.
Importance 100 Sentiment -50
priv
Bernstein Liebhard LLP
Bernstein Liebhard LLP is representing investors in a class action lawsuit against UniQure, seeking to recover losses for shareholders. This action enhances the firm's reputation and business.
Importance 80 Sentiment 50
govactor
United States===United States District Court for the Southern District of New York
The United States===United States District Court for the Southern District of New York is the venue where the class action lawsuit against UniQure was filed and will be adjudicated.
Importance 30 Sentiment 0
exch
Nasdaq
Nasdaq is the stock exchange where UniQure's shares are traded. The lawsuit may cause fluctuations in UniQure's stock price on Nasdaq.
Importance 10 Sentiment 0
Relationships
Bernstein Liebhard LLP related ↔ UniQure
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.